These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 29527938)
21. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma. Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397 [TBL] [Abstract][Full Text] [Related]
22. The Reintroduction of Radiotherapy Into the Integrated Management of Kidney Cancer. Dohopolski M; Hannan R; Wardak Z; Hammers H; Garant A Cancer J; 2020; 26(5):448-459. PubMed ID: 32947313 [TBL] [Abstract][Full Text] [Related]
23. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Sahgal A; Ma L; Weinberg V; Gibbs IC; Chao S; Chang UK; Werner-Wasik M; Angelov L; Chang EL; Sohn MJ; Soltys SG; Létourneau D; Ryu S; Gerszten PC; Fowler J; Wong CS; Larson DA Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):107-16. PubMed ID: 20951503 [TBL] [Abstract][Full Text] [Related]
25. Trends in stereotactic body radiation therapy for stage I small cell lung cancer. Stahl JM; Corso CD; Verma V; Park HS; Nath SK; Husain ZA; Simone CB; Kim AW; Decker RH Lung Cancer; 2017 Jan; 103():11-16. PubMed ID: 28024690 [TBL] [Abstract][Full Text] [Related]
26. Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma. Yamamoto T; Kadoya N; Takeda K; Matsushita H; Umezawa R; Sato K; Kubozono M; Ito K; Ishikawa Y; Kozumi M; Takahashi N; Katagiri Y; Onishi H; Jingu K Radiat Oncol; 2016 May; 11():72. PubMed ID: 27229710 [TBL] [Abstract][Full Text] [Related]
27. [The therapeutic potential of ablative radiotherapy for metastatic renal cell cancer: a tumour deemed radiation resistant]. Coucke P; Jánváry Z; Jansen N Rev Med Liege; 2014; 69 Suppl 1():94-100. PubMed ID: 24822313 [TBL] [Abstract][Full Text] [Related]
28. Stereotactic body radiation therapy (SBRT): A new treatment option in renal cancer. Couñago F; López-Campos F Actas Urol Esp (Engl Ed); 2024 May; 48(4):260-261. PubMed ID: 37984716 [No Abstract] [Full Text] [Related]
29. Stereotactic body radiation therapy for metastases to the kidney in patients with non-small cell lung cancer: a new treatment paradigm for durable palliation. Verma V; Simone CB Ann Palliat Med; 2017 Apr; 6(2):96-103. PubMed ID: 28480719 [TBL] [Abstract][Full Text] [Related]
30. Locally advanced renal cell carcinoma: low complication rate and efficacy of postnephrectomy radiation therapy planned with CT. Kao GD; Malkowicz SB; Whittington R; D'Amico AV; Wein AJ Radiology; 1994 Dec; 193(3):725-30. PubMed ID: 7972814 [TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases. Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):556-63. PubMed ID: 25680599 [TBL] [Abstract][Full Text] [Related]
32. Racial disparities in the use of SBRT for treating early-stage lung cancer. Corso CD; Park HS; Kim AW; Yu JB; Husain Z; Decker RH Lung Cancer; 2015 Aug; 89(2):133-8. PubMed ID: 26051446 [TBL] [Abstract][Full Text] [Related]
33. Stereotactic body radiation therapy (SBRT) for genitourinary malignancies. Teh BS; Ishiyama H; Mathews T; Xu B; Butler EB; Mayr NA; Lo SS; Lu JJ; Blanco AI; Paulino AC; Timmerman RD Discov Med; 2010 Sep; 10(52):255-62. PubMed ID: 20875347 [TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases. Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057 [TBL] [Abstract][Full Text] [Related]
35. Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: a case report. Hilleary LA; Wratten C; Siva S; Hilleary J; Martin JM BMC Cancer; 2019 Jul; 19(1):671. PubMed ID: 31286870 [TBL] [Abstract][Full Text] [Related]
36. [Stereotactic body radiation therapy for primary kidney cancer]. Abancourt L; Le Guévelou J; Taillez A; Vu A; de Crevoisier R; Supiot S; Hennequin C; Chapet O; Blanchard P; Mirabel X; Lartigau É; Pasquier D Cancer Radiother; 2023 Sep; 27(6-7):568-572. PubMed ID: 37543493 [TBL] [Abstract][Full Text] [Related]
37. Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. Alongi F; Arcangeli S; Triggiani L; Mazzola R; Buglione di Monale E Bastia M; Fersino S; Baiguini A; Jereczek-Fossa BA; Magrini SM; Crit Rev Oncol Hematol; 2017 Sep; 117():48-56. PubMed ID: 28807235 [TBL] [Abstract][Full Text] [Related]
38. Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT). Altoos B; Amini A; Yacoub M; Bourlon MT; Kessler EE; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD Radiat Oncol; 2015 Oct; 10():218. PubMed ID: 26510665 [TBL] [Abstract][Full Text] [Related]
39. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571 [TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma. Ranck MC; Golden DW; Corbin KS; Hasselle MD; Liauw SL; Stadler WM; Hahn OM; Weichselbaum RR; Salama JK Am J Clin Oncol; 2013 Dec; 36(6):589-95. PubMed ID: 22868242 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]